BENJAMIN MCALLISTER: Open Payments
NPI 1356600118 · GREENFIELD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$258 in 14 payments from 9 companies in 2025. Trend: 2023 $43 · 2024 $377 · 2025 $258
Food & beverage: $258
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $78 |
| Janssen Pharmaceuticals, Inc | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Corium, LLC | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $14 |
Products named: VRAYLAR, SPRAVATO, CAPLYTA, FANAPT, Azstarys, REXULTI, TRINTELLIX, COBENFY.
Industry payments across IN — which companies pay providers there.
